Previous 10 | Next 10 |
NEW HAVEN, Conn., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), today announced the results of three key performance metrics that together demonstrate the continued growth and positive impact of the sales force’s expansi...
NEW HAVEN, Conn., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) will be hosting its Second quarter 2019 corporate update call on Wednesday, August 21 st at 5:00 PM ET, following its recent filing of its Form 10-Q on August...
NEW HAVEN, Conn., July 22, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc . ( NASDAQ: PRPO ), announced today that in conjunction with its global expansion efforts, it has begun to establish distribution partnerships in Asia, which may yield early stage revenues a...
Thoughts about performance presentation Due to a mix of personal, professional and technical reasons more than 3 weeks have passed since my last article "Do Not Sell In May (June) And Go Away; Look At These Buy Candidates" was published. There have been interesting developments both in the...
Gainers: Infrastructure and Energy Alternatives (NASDAQ: IEA ) +47% . SSLJ.com (YGTY) +23% . Emmis Communications Corporation (NASDAQ: EMMS ) +24% . Pioneer Power Solutions (NASDAQ: PPSI ) +17% . Seadrill (NYSE: SDRL ) +17% . Ovid Therapeutics (NASDAQ: OVID ) +15% . NeoPhotonic...
Gainers: Infrastructure and Energy Alternatives (NASDAQ: IEA ) +47% . SSLJ.com (YGTY) +23% . Emmis Communications Corporation (NASDAQ: EMMS ) +24% . Pioneer Power Solutions (NASDAQ: PPSI ) +17% . Seadrill (NYSE: SDRL ) +17% . Ovid Therapeutics (NASDAQ: OVID ) +15% . NeoPhotonic...
NEW HAVEN, Conn., June 25, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced the initiation of a second development project with H3 Biomedicine that will include the creation of a targeted gene panel. The panel will include a pre-amplifi...
Intro to my approach You might have noticed in my previous articles how I mentioned this or that ticker as a result of running this or that screen. Indeed, I had, until 2 weeks ago, worked for over 6 months on performing hundreds and hundreds of backtests based on a number of multi-factor st...
NEW HAVEN, Conn., June 17, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), provides an update to its shareholders. Dear Investors: We are all aware of the recent pricing pressure on Precipio’s stock. To this end, we would like to pro...
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that it has entered into an exclusive subcontracting manufacturing agreement with diagnostics manufacturing company Novamed for the production of Precipio...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today no later than 11pm Eastern Time. In order to e...